We came across a bullish thesis on Amgen Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.'s share was trading at $382.87 as of February 24th. AMGN’s trailing and forward P/E were 24.32 and 13.74, respectively according to Yahoo Finance.
[caption id="attachment_400243" align="aligncenter" width="750"]Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. AMGN is attracting bullish positioning after a trader sold 1,000 June 18, 2026...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.